Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Depreciation & Amortization - Total (2013 - 2014)

Updated

Dr Reddys Laboratories (RDY) posted Depreciation & Amortization - Total of $31 million for fiscal Q4 2014 (quarter ended Mar 31, 2014), down 6.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Depreciation & Amortization - Total (2013 - 2014) Analysis & Trends

For the trailing twelve months through Mar 31, 2014, Depreciation & Amortization - Total at Dr Reddys Laboratories was $1.39 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 31.00 Mn
Dec 31, 2013 33.00 Mn
Jun 30, 2013 1.17 Bn
API Access

Dr Reddys Laboratories Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=RDY&period=max&api_key=YOUR_API_KEY